TGFβ Signaling and Cardiovascular Diseases

被引：2

作者：

Pardali, Evangelia ^{[1
]}

ten Dijke, Peter ^{[2
,3
]}

机构：

[1] Univ Hosp Munster, Dept Cardiol & Angiol, Munster, Germany

[2] Leiden Univ, Med Ctr, Ctr Biomed Genet, Leiden, Netherlands

[3] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands

来源：

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | 2012年 / 8卷 / 02期

关键词：

atherosclerosis; BMP; hypertension; Smad; TGF beta; vessel calcification; TRANSFORMING-GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; BONE MORPHOGENETIC PROTEIN; HEREDITARY HEMORRHAGIC TELANGIECTASIA; PULMONARY ARTERIAL-HYPERTENSION; NITRIC-OXIDE SYNTHASE; HUMAN ATHEROSCLEROTIC LESIONS; VASCULAR ENDOTHELIAL-CELLS; AORTIC-ANEURYSM PROGRESSION; RECEPTOR-LIKE KINASE-1;

D O I：

10.7150/ijbs.8.195

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Transforming growth factor beta (TGF beta) family members are involved in a wide range of diverse functions and play key roles in embryogenesis, development and tissue homeostasis. Perturbation of TGF beta signaling may lead to vascular and other diseases. In vitro studies have provided evidence that TGF beta family members have a wide range of diverse effects on vascular cells, which are highly dependent on cellular context. Consistent with these observations genetic studies in mice and humans showed that TGF beta family members have ambiguous effects on the function of the cardiovascular system. In this review we discuss the recent advances on TGF beta signaling in (cardio) vascular diseases, and describe the value of TGF beta signaling as both a disease marker and therapeutic target for (cardio) vascular diseases.

引用

页码：195 / 213

页数：19

共 50 条

[31] TGF-β signaling in the kidney: profibrotic and protective effects
Sureshbabu, Angara
Muhsin, Saif A.
Choi, Mary E.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 310 (07) : F596 - F606
[32] The DAN family: Modulators of TGF-β signaling and beyond
Nolan, Kristof
Thompson, Thomas B.
PROTEIN SCIENCE, 2014, 23 (08) : 999 - 1012
[33] The regulation of TGF-β/SMAD signaling by protein deubiquitination
Zhang, Juan
Zhang, Xiaofei
Xie, Feng
Zhang, Zhengkui
van Dam, Hans
Zhang, Long
Zhou, Fangfang
PROTEIN & CELL, 2014, 5 (07) : 503 - 517
[34] TGF-β and BMPR2 Signaling in PAH: Two Black Sheep in One Family
Rol, Nina
Kurakula, Konda Babu
Happe, Chris
Bogaard, Harm Jan
Goumans, Marie-Jose
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (09)
[35] Therapeutic Approaches for Treating Pulmonary Arterial Hypertension by Correcting Imbalanced TGF-β Superfamily Signaling
Andre, Patrick
Joshi, Sachindra R.
Briscoe, Steven D.
Alexander, Mark J.
Li, Gang
Kumar, Ravindra
FRONTIERS IN MEDICINE, 2022, 8
[36] The role of TGF-β superfamily signaling in neurological disorders
Kashima, Risa
Hata, Akiko
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2018, 50 (01) : 106 - 120
[37] TGF-β receptors: In and beyond TGF-β signaling
Ark, Alexandra Vander
Cao, Jingchen
Li, Xiaohong
CELLULAR SIGNALLING, 2018, 52 : 112 - 120
[38] The Roles of Primary Cilia in Cardiovascular Diseases
Pala, Rajasekharreddy
Jamal, Maha
Alshammari, Qamar
Nauli, Surya M.
CELLS, 2018, 7 (12)
[39] A novel peptide adropin in cardiovascular diseases
Li, Liang
Xie, Wei
Zheng, Xi-Long
Yin, Wei-Dong
Tang, Chao-Ke
CLINICA CHIMICA ACTA, 2016, 453 : 107 - 113
[40] cGMP Signaling in Cardiovascular Diseases: Linking Genotype and Phenotype
Dang, Tan An
Schunkert, Heribert
Kessler, Thorsten
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 75 (06) : 516 - 525

← 1 2 3 4 5 →